Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AZZ INC Director's Dealing 2018

Jul 12, 2018

31310_dirs_2018-07-12_48d131ce-cbf9-4796-be77-4f8ec5a64664.zip

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AZZ INC (AZZ)
CIK: 0000008947
Period of Report: 2018-07-10

Reporting Person: BERCE DANIEL E (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-07-10 COMMON STOCK A 1823 Acquired 62747 Direct
2018-07-11 COMMON STOCK M 2724 $25.67 Acquired 65471 Direct
2018-07-11 COMMON STOCK F 1449 $54.85 Disposed 64022 Direct
2018-07-11 COMMON STOCK M 1362 $45.36 Acquired 65384 Direct
2018-07-11 COMMON STOCK F 235 $54.85 Disposed 65149 Direct
2018-07-11 COMMON STOCK M 1603 $43.92 Acquired 66752 Direct
2018-07-11 COMMON STOCK F 319 $54.85 Disposed 66433 Direct
2018-07-11 COMMON STOCK S 2003 $54.30 Disposed 64430 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-07-11 STOCK APPRECIATION RIGHTS $ M 2724 Disposed COMMON STOCK (2724.0) Direct
2018-07-11 STOCK APPRECIATION RIGHTS $ M 1362 Disposed COMMON STOCK (1362.0) Direct
2018-07-11 STOCK APPRECIATION RIGHTS $ M 1603 Disposed COMMON STOCK (1603.0) Direct

Footnotes

F1: Conversion of stock appreciation rights ("SARs"), which are settled in shares of AZZ common stock in an amount equal to the excess value of the grant date price ($25.67) over the exercise price ($54.85).

F2: Conversion of SARs, which are settled in shares of AZZ common stock in an amount equal to the excess value of the grant date price ($45.36) over the exercise price ($54.85).

F3: Conversion of SARs, which are settled in shares of AZZ common stock in an amount equal to the excess value of the grant date price ($43.92) over the exercise price ($54.85).

F4: The shares sold on the open market are the aggregate net shares received upon the exercise of the SARs reported in Table I.

F5: On March 1, 2012 the reporting person was granted SARs, which vested ratably over a 3-year period beginning on March 1, 2013.

F6: The SARs granted on March 1, 2012 have an expiration date of March 1, 2019.

F7: On March 1, 2013 the reporting person was granted SARs, which vested ratably over a 3-year period beginning on March 1, 2014.

F8: The SARs granted on March 1, 2013 have an expiration date of March 1, 2020.

F9: On March 1, 2014 the reporting person was granted SARs, which vested ratably over a 3-year period beginning on March 1, 2015.

F10: The SARs granted on March 1, 2014 have an expiration date of March 1, 2021.